baber/WOPTO huggingface dataset:
Patent AU-1628999-A (AU)
Title: Ceramic composite electrolytic device and methods for manufacture thereof
Inventor: CUBUKCU ESIN
IPC: C04B35/465
Filed: 1998-12-04
Abstract: An oxygen or ozone generating device having a plurality of ceramic composite cells, a resistance heat element, a cathode, an anode, a gas manifold interconnecting a gas output passageway from each of the cells, and a thermal shell in which the ceramic composite cells are stacked or arranged in electrical series and gas parallel surrounded by shock absorbing and insulating materials, respectively. Also provided are an exhaust fan, thermocouple sensors, a power source, a programmable computer controller with user interface, and a container supporting the computer user interface and having passageways for providing air into the device, and an oxygen output for supplying oxygen from the device. Methods for manufacturing the ceramic composite cells are also provided, including a method for manufacturing bismuth baria oxide and bismuth calcia baria oxide for use in the ceramic materials used within the ceramic composite cell.
Patent AU-1671883-A (AU)
Title: Carbacyclin pharmaceutical preparations
Inventor: SKUBALLA WERNER
IPC: C07C405/00
Filed: 1983-07-11
Abstract: Carbacylin derivatives of the general formula I <IMAGE>  in which   R1 denotes a hydrogen atom or the radical OR2, in which R2 can denote hydrogen, alkyl, cycloalkyl, aryl, the radical <IMAGE> or a heterocyclic radical, or R1 can denote the radical NHR3 where R3 denotes an acid radical or the radical R2, n can denote the number 2, 3, 4 or 5, X denotes a hydrogen atom or a fluorine atom,    A denotes a -CH2-CH2-, a trans -CH=CH- or -C IDENTICAL C- group,   W denotes a free or functionally modified hydroxymethylene group or a free or functionally modified <IMAGE> group, in which the OH group can be in the  alpha  or  beta position,    D denotes the group <IMAGE> a straight-chain, saturated alkylene group having 1-5 C atoms, a branched saturated or a straight-chain or branched unsaturated alkylene group having 2-5 C atoms, which may be substituted by fluorine atoms,    m can denote the number 1, 2 or 3,   E represents a direct bond, a -C IDENTICAL C- group or a -CR6=CR7- group, in which R6 denotes a hydrogen atom or an alkyl group having 1-5 C atoms and R7 denotes a hydrogen atom, an alkyl group having 1-5 C atoms or a halogen atom,   R4 denotes an alkyl, cycloalkyl or a substituted or unsubstituted aryl group or a heterocyclic group,    R5 denotes a free or functionally modified hydroxyl group, and, if R2 denotes a hydrogen atom, the salts thereof with physiologically acceptable bases, a process for their preparation and their use as pharmaceuticals.
Patent AU-1714095-A (AU)
Title: Therapeutic benzonitriles
Inventor: CHAN JOSEPH HOWING
IPC: A61P29/00
Filed: 1995-02-23
Abstract: Arylthiobenzonitrile compounds of formula (I) wherein: R is hydrogen, C1-4 alkyl, C1-4 alkoxy, hydroxyl, mercapto, NR<1a>R<2a> or SR<1a> (wherein R<1a> and R<2a>, which may be the same or different are, hydrogen, C1-4 alkyl or phenyl C1-4 alkyl); R<1>, R<2>, m and n have the meanings given in the description; or a physiologically functional derivative thereof, pharmaceutical formulations containing them, processes for their preparation and their use in therapy for the prophylaxis or treatment of HIV infection or inflammation are disclosed.
Patent AU-1901501-A (AU)
Title: Antimcrobial activity of the first cationic cluster of human lactoferrin
Inventor: BERKEL PATRICK HENDRIKUS CORNE
IPC: C07K14/79
Filed: 2000-11-10
Abstract: The present invention provides polypeptides related to human lactoferrin protein that have utility in a variety of therapeutic and prophylactic applications, including use as antimicrobial agents. The invention further provides pharmaceutical compositions containing these polypeptides and therapeutic methods using such compositions. Methods for detecting antimicrobial infections using the polypeptides are also provided.
Patent AU-1955295-A (AU)
Title: Aqueous ophthalmic sprays
Inventor: ROWE RAYMOND CHARLES
IPC: A61M11/00
Filed: 1995-03-23
Abstract: A method of administering to the eye a liquid ophthalmic formulation, comprising an ophthalmologically acceptable liquid and optionally containing an ophthalmologically-active substance, characterized in that the formulation has a viscosity in the range 10<-><3> to 1.0Pa.s and a resistivity lower than 10<4>ohm.cm, and that a jet of the formulation is ejected towards the eye, from a spray nozzle (12) situated adjacent to a piezoelectric or electromagnetic transducer (7), to form a stream of uniformly-sized, equally spaced, uncharged droplets, the stream of uncharged droplets is subsequently directed past a charging electrode (13) to induce an electric charge on each droplet in the stream, and the charged droplets discharge their electric charge by earthing on contact with the eye; and spraying apparatus suitable for use in that method. <IMAGE>
Patent AU-2015095-A (AU)
Title: Mucosal administration of pneumococcal antigens
Inventor: BRILES DAVID E
IPC: A61P31/04
Filed: 1995-05-19
Abstract: Mucosal administration, particularly intranasally, of killed whole pneumococci, lysate of pneumococci and isolated and purified PspA, as well as immunogenic fragments thereof, particularly when administered with cholera toxin B subunit, provides protection in animals against pneumococcal colonization and systemic infection. The ability to elicit protection against pneumococcal colonization in a host prevents carriage among immunized individuals, which can lead to elimination of disease from the population as a whole.
Patent AU-2047100-A (AU)
Title: System and method for generating video taping reminders
Inventor: HELMSTETTER GARY
IPC: H04N5/445
Filed: 1999-12-07
Abstract: Electronic Guide products give the user the ability to videotape selected programs. Once a program has successfully been taped a message is displayed, reminding the viewer that they have taped it. (E.g. "You taped Xxxxx; have you watched it yet?") Information comprising information that shows are taped, the particular shows taped and viewer profiles allow advertisements targeted to the viewer who typically records a given type of programming to be presented. In an embodiment the display of the reminders is made conditional upon acceptance of advertising (for example, based on a piece of data transmitted along with other data related to that show), and can be sold to the broadcasters who transmitted the show. This information is marketed as a peculiarly well-targeted ad for the show, causing it to continue to produce value for the broadcaster after the broadcast is complete. Broadcasters, in turn, may offer the reminders to major advertisers as they sell commercial air time during the show, as a premium feature of the air time. The advertisement may be sent over channels comprising the video blanking interval, the Internet or on another channel.
Patent AU-2103683-A (AU)
Title: Hydroxy-azolyl derivatives
Inventor: KRAMER WOLFGANG
IPC: A01N43/653
Filed: 1983-11-07
Abstract: Heterocyclyl-hydroxyalkyl-azolyl derivatives of the formula <IMAGE>  (I)  in which Az represents 1,2,4-triazol-1-yl, 1,2,4-triazol-4-yl or imidazol-1-yl, Het represents optionally substituted dioxolanyl or 1,3-dioxanyl, R represents alkyl, optionally substituted phenyl, optionally substituted phenylalkyl, optionally substituted phenoxyalky, optionally substituted phenylthioalkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, alkenyl, optionally substituted phenylalkenyl, optionally substituted cyclohexylalkenyl, furyl, naphthyloxymethyl or azolylalkyl, R' represents hydrogen, optionally substituted alkyl or alkenyl and n represents the number 0 or 1, or addition products thereof with acids or metal salts, which possess fungicidal activity.
Patent AU-2109601-A (AU)
Title: Osmotic beneficial agent delivery system
Inventor: FERREIRA PAMELA
IPC: A61K9/22
Filed: 2000-12-13
Abstract: An osmotic beneficial agent delivery system includes an implantable osmotic delivery device and a catheter for delivery of the beneficial agent from the delivery device to a delivery location. The beneficial agent delivery system includes a catheter and a docking station which are implanted in the patient with a distal end of the catheter positioned at a delivery site. The catheter and docking station are left in place while an implant containing the beneficial agent is removably connected to the catheter at the docking station and can be replaced as needed. The docking station provides a connection between a catheter and the implant allowing the implant to be replaced periodically while the catheter and the docking station remain in place.
Patent AU-2299388-A (AU)
Title: Homogeneous t-4 uptake assay
IPC: G01N33/78
Filed: 1988-09-30
Abstract: The present invention provides an improved assay for measuring thyroxine uptake by thyroxine binding globulin in which thyroxine binding globulin (TBG) activity is measured directly. The method comprises combining a sample in an aqueous solution with an enzyme donor (ED) conjugated to an analogue of polyiodothyronine that competes with thyroxine for thyroxine binding globulin binding sites. An enzyme acceptor (EA) characterized by providing a modulated enzyme activity in relation to the amount of TBG activity is combined with an enzyme donor and sample in an aqueous solution. The amount of enzyme activity in comparison to a control solution having a known amount of available TBG binding sites is determined.
Patent AU-2329888-A (AU)
Title: Apparatus for and method of providing improved gas separation
Inventor: KRASBERG ALAN
IPC: B01D53/22
Filed: 1988-09-01
Abstract: PCT No. PCT/GB88/00719 Sec. 371 Date Apr. 2, 1990 Sec. 102(e) Date Apr. 2, 1990 PCT Filed Sep. 1, 1988 PCT Pub. No. WO89/01819 PCT Pub. Date Mar. 9, 1989.A method of, and apparatus for, providing improved separation of gases in a gas mixture using particularly, but not exclusively, permeable membranes (28). In passing over a membrane (28), a portion of a gas mixture in intimate contact with the membrane wall experiences a change in density as components of the gas selectively diffuse through the membrane (28). In particular, the present invention uses gravity or other force to act on the density difference created by diffusion to assist in a) "peeling" (away from the wall) the gas which has already undergone substantial diffusion: b) keeping this gas away from the diffusion surface, once it has left; c) removing the gas from the membrane (28) more quickly; and d) slowing gas which has had less exposure to the diffusion process and moving it towards the membrane wall. Embodiments of the invention are described.
Patent AU-2389201-A (AU)
Title: Signal routing
Inventor: NAKAGAWA TOMOHIRO
IPC: H04B7/26
Filed: 2000-12-20
Abstract: A method for routing communications in a communications system comprising a plurality of communication nodes, each node being capable of transmitting signals to and receiving signals from one or more other nodes, and including a first node, a second node and a plurality of other nodes; the method comprising selecting a route for communications from the first node to the second node by way of at least one of the other nodes on the basis of mobility characteristics and/or energy characteristics of each of the other nodes.
Patent AU-2433601-A (AU)
Title: Rapid exchange catheter having a support mandrel
Inventor: EL-NOUNOU FOZAN
IPC: A61M29/02
Filed: 2000-12-14
Abstract: Rapid exchange catheters having improved pushability and trackability due to a support mandrel disposed within the inflation lumen. The mandrel is secured at the proximal end of the catheter shaft while the free distal end extends beyond the proximal guidewire port. In an alternative embodiment, the catheter shaft further comprises a sleeve in the inflation lumen that secures a distal section of the support mandrel. The distal end of the mandrel extends beyond the sleeve.
Patent AU-2731999-A (AU)
Title: Stable homogeneous emulsifier-free suspension, preparation method and uses in food compositions
Inventor: DOAT STEPHANE
IPC: A23L29/262
Filed: 1999-03-04
Abstract: The invention concerns a stable homogeneous emulsifier-free suspension of at least one hydrophobic substance and/or a substance whereof the melting point is higher than about 130° C., and a thickening agent, in an aqueous medium. Said suspensions can be used in food compositions, in particular based on milk and milk derivatives.
Patent AU-2856897-A (AU)
Title: Method and appliance for conditioning and pollution control of water
Inventor: KOSLOWSKY PETER
IPC: C02F1/66
Filed: 1997-07-10
Abstract: A process for treating and purifying water for swimming pools uses water softeners, filters, pumps and pipes for circulating water. The water is treated with ion exchangers (6) to remove acids and water hardness components and the softened water is used to fill a pool (1). Lime water (8), comprising a clear saturated solution of (hydrated) lime in water, is added to the pool to create a lime-carbonic acid equilibrium which converts any carbon dioxide in the water into carbonate in order to precipitate phosphate and sulphate as sparingly soluble calcium salts, as well precipitating body substances (eg. dead skin), creams and bath oils as lime soaps. Inorganic oxidation products generated by sunlight are precipitated as calcium ions, and small suspension or sediment solids not normally capable of being filtered are adsorbed onto calcite. The water is passed continuously through a cycle consisting of pipes (13, 19, 20) , pumps (17), valves (14, 18) and filters, forcing at least some of the water to flow a bed of crushed limestone to keep pH above 7. More limewater is optionally added to maintain the lime-carbonic acid equilibrium. Lost water is replenished with fresh acid- and hardness-free water to prevent water in the pool becoming too salty. The apparatus is also claimed.
Patent AU-2865492-A (AU)
Title: T cell epitopes of the major allergens from dermatophagoides(house dust mite)
Inventor: ROGERS BRUCE L
IPC: A61K39/35
Filed: 1992-10-15
Abstract: The present invention provides isolated peptides of the major protein allergens of the genus Dermatophagoides. Peptides within the scope of the invention comprise at least one T cell epitope, or preferably at least two T cell epitopes of a protein allergen selected from the allergens Der p I, Der p II, Der f I, or Der f II. The invention also pertains to modified peptides having similar or enhanced therapeutic properties as the corresponding, naturally-occurring allergen or portion thereof, but having reduced side effects. The invention further provides nucleic acid sequences coding for peptides of the invention. Methods of treatment or of diagnosis of sensitivity to house dust mites in an individual and therapeutic compositions comprising one or more peptides of the invention are also provided.
Patent AU-2895084-A (AU)
Title: Magnetic tachometer for disk drives
Inventor: HEARN PATRICK L
IPC: G01P3/46
Filed: 1984-06-01
Abstract: A magnetic tachometer for generating a signal as a function of the velocity of a transducer positioning arm in a disk drive. The tachometer is formed by a pair of fixed parallel coils separated by a distance sufficient to allow a magnet, attached to a counterbalance portion of the rotary positioning arm, to move therebetween and thus to generate a voltage as a function of the velocity of the magnet. The coils are each wound over a thin armature member which is saturated by the magnet's magnetic field and they are differentially coupled to produce common mode rejection.
Patent AU-2908697-A (AU)
Title: Process for preparing 3-isochromanone
Inventor: JONES RAYMOND VINCENT HEAVON
IPC: B01J27/08
Filed: 1997-05-21
Abstract: PCT No. PCT/GB97/01391 Sec. 371 Date Dec. 14, 1998 Sec. 102(e) Date Dec. 14, 1998 PCT Filed May 21, 1997 PCT Pub. No. WO97/48692 PCT Pub. Date Dec. 24, 19973-Isochromanone is prepared by reacting o-tolyacetic acid with sulphuryl chloride in the presence of a free radical initiator, e.g. AIBN, followed by ring closure of the 2-chloromethylphenylacetic acid so formed with a base, e.g. potassium bicarbonate.
Patent AU-2943097-A (AU)
Title: Diamond
Inventor: COLLINS JOHN LLOYD
IPC: C23C16/26
Filed: 1997-07-23
Abstract: A CVD diamond layer for use as an insert in an abrasive tool characterised by the following features:   (i) the layer contains boron dopant atoms in a concentration of at least 0,05 atomic percent; (ii) an average tensile rupture strength of at least 600MPa with the nucleation phase in tension, and at least 300MPa with the growth face in tension, both such tensile rupture strengths being measured by a three point bend test on a sample 18mm long, 2mm wide and a thickness of 1,4mm or smaller.
Patent AU-2947092-A (AU)
Title: Automatic clutch control method and associated automatic transmission device
IPC: F16D48/06
Filed: 1992-10-14
Abstract: The epicyclic gear train consists of a driving shaft and pinion (1,3), satellite pinions (4), unidirectional crown wheel (7) and clutch (14,15). The clutch operates between the crown wheel and a satellite bearer wheel (5) attached to the output shaft (6). At high speeds increasing centrifugal force acting on plates (31) opens the clutch, lowering the gear ratio which is restored to direct drive at lower speeds. Heavy accelerator pressure operates an electromagnet (123,124) which delays clutch opening as does high input torque through an axial force (FAC) at the helicoidal gears (7). <IMAGE>
Patent AU-3165101-A (AU)
Title: Method and device for cooling a hot reactor gas, for example in the production of phthalic anhydride
Inventor: WILKE ALFRED
IPC: B01J19/00
Filed: 2000-12-29
Abstract: Cooling of a hot reaction gas prior to its entry into a separator (121) is such that a heat-exchanger (127) containing a flowing cooling medium is provided, the hot gas being led through the exchanger.
Patent AU-3200584-A (AU)
Title: Alpha-allenic-alpha amino acids
Inventor: KRANTZ ALEXANDER
IPC: A61K31/395
Filed: 1984-08-16
Abstract: Novel alpha-allenic-alpha-amino acids which are enzyme inhibitors of the suicide or kcat, type are disclosed herein.
Patent AU-3338897-A (AU)
Title: Catalytic distillation
Inventor: BROCKER FRANZ JOSEF
IPC: B01J19/32
Filed: 1997-06-16
Abstract: A catalyst packing which can be produced by vapor deposition and/or sputtering of at least one substance active as catalyst and/or promotor onto woven or knitted fabrics or sheets as support material is used in a process for catalytic distillation in which a heterogeneously catalyzed reaction is combined with a simultaneous distillation or rectification over the catalyst packing.
Patent AU-3424797-A (AU)
Title: Process for producing a foaming slag above a stainless steel melted in an electric furnace
Inventor: GUILLOT YVES
IPC: C21C5/54
Filed: 1997-08-19
Abstract: A method of forming a foamed slag on a stainless steel melt in an electric furnace involves introducing, into the slag, a powder containing metal oxide and carbon which react to form bubbles of the reduced metal vapour and carbon monoxide and thus create a stable foam. The metal oxide is an oxide of a volatile metal, especially zinc or lead, and at least part of the powder is dust from an electric steel making furnace.
Patent AU-3488284-A (AU)
Title: 1-phenyl-1-tetrahydronapthyl-ethane dielectric fluid
Inventor: GUNTER WOLFGANG
IPC: H01B3/22
Filed: 1984-10-31
Abstract: 1-phenyl-1-tetrahydronaphthyl-ethane or an alkyl-substituted derivative thereof is useful as dielectric fluid in capacitors and undersea power cables having low flammability, high aromaticity and high density.
Patent AU-3691189-A (AU)
Title: Tablet formulations of pesticides
Inventor: MOORE EARL PHILLIP
IPC: A01N25/30
Filed: 1989-05-17
Abstract: A tablet formulation comprising (i) a pesticide characterized by low or no water solubility, and (ii) a complementary delivery system containing an organic acid, an inorganic base, a dispersant, a disintegrant, and a wetting agent.
Patent AU-3705693-A (AU)
Title: Photovoltaic element and method of forming the same
Inventor: TSUZUKI KOJI
IPC: H01L31/0224
Filed: 1993-04-21
Abstract: A photovoltaic element has a photoelectric conversion layer and a collecting electrode formed by curing a paste having at least an electroconductive base substance and a curable resin on the photoelectric conversion layer. The number average molecular weight of the curable resin is 3000 or less. <IMAGE>
Patent AU-3859289-A (AU)
Title: Biocidal protective coating for heat exchanger coils
Inventor: TERRY CLAUDE EDWARD
IPC: A01N25/34
Filed: 1989-06-23
Abstract: An biocidal protective coating and an method for coating heat exchanger coils, which includes a polymeric composition comprising an organic water resistant polymer and a compound of the general formula <IMAGE>   wherein X is selected from the group consisting of organic ions, HT, Group I metals, Group II metals and transition metals, R and R' are independently selected from the group consisting of hydrocarbons and substituted hydrocarbons of not more than 24 carbon atoms, and there is at least one free hydroxyl group.
Patent AU-3888993-A (AU)
Title: A salt product and a method for the preparation thereof
Inventor: FREDERIKSEN WILMAR FRIIS
IPC: A23L27/40
Filed: 1993-03-18
Abstract: PCT No. PCT/DK93/00100 Sec. 371 Date Sep. 16, 1994 Sec. 102(e) Date Sep. 16, 1994 PCT Filed Mar. 18, 1993 PCT Pub. No. WO93/18668 PCT Pub. Date Sep. 30, 1993A salt product comprising particles of NaCl, K/Mg-double salts and optionally KCl homogeneously distributed throughout each particle and having a molar ratio of K to Mg>/=1. The product may be obtained from an aqueous salt mixture, preferably a solution containing the desired proportion of salt ions and having a water content of 50 to 90% by weight by subjecting the aqueous salt mixture to instant drying at a temperature of 70 DEG  to 200 DEG  C. for a period of 1 to 60 seconds to obtain a dry product. The product is usable as a low sodium substitution for common salt in connection with the preparation of food, beverages or pharmaceutical products and/or as a preservative or water binding agent.
Patent AU-4074801-A (AU)
Title: Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
Inventor: AVRAMEAS EUSTRATE
IPC: A61K47/48
Filed: 2001-03-01
Abstract: Amino acid sequences (I) that facilitate penetration of a substance of interest (II) into the inside of a cell and/or its nucleus. (I) can react in vivo with aminoglycans (AG) or can react with AG (sic) and are derived from proteins of human origin. Independent claims are also included for the following: (1) associations of (I) and (II); (2) intracytoplasmic and/or intranuclear transfer vectors consisting of, or containing, at least one (I); (3) eukaryotic cells that contain (I) or the vector of (2) or are transfected with this vector; (4) process for in vitro transfer of (II) into cells; (5) composition (biological, pharmaceutical, cosmetic, nutritional, diagnostic or tracer) containing as active agent a vector of (2) or a cell of (3); (6) diagnostic agent comprising the vector of (2) or the cells of (3); and (7) diagnostic kit containing, in one or more vessels, a predetermined quantity of the composition of (5). ACTIVITY : Antiviral; antibacterial; cytostatic; anti-apoptotic; vasotropic; hemostatic. No supporting data given. MECHANISM OF ACTION : Gene or protein replacement; gene therapy. No supporting data given.
Patent AU-4140689-A (AU)
Title: Pyridoindole derivatives and processes for preparation thereof
Inventor: KATO MASAYUKI
IPC: A61P1/00
Filed: 1989-09-14
Abstract: A compound of the formula : <CHEM>  wherein  R<1> is hydrogen, lower alkyl or lower alkenyl  R<2> is hydrogen, lower alkyl or halogen, R<3> is imidazolyl or pyridyl, each of which may have suitable substituent(s), and R<4> is hydrogen, lower alkyl, lower alkenyl or hydroxy(lower)alkyl and R<5> is hydrogen, hydroxy or acyloxy, or  R<4> and R<5> are linked together to form an additional bond, and pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions comprising them in association with the pharmaceutically acceptable, substantially non-toxic carrier or excipient.